An analysis of the funding models, economic value, and broader societal benefits of pharmacy-based vaccination (PBV) services worldwide is published in a new FIP report today.

Drawing on global data and case studies from FIP reports and literature, it offers insights into how pharmacist-led vaccination supports public health and generates cost savings across diverse health systems. The publication explores challenges to sustainable financing of PBV, the economic case for investment in pharmacist-administered vaccines, and strategies to ensure timely vaccine procurement. It highlights both direct and indirect savings generated through PBV, including improved immunisation coverage, reduced burden of vaccine-preventable diseases, and enhanced productivity.

With a comprehensive set of recommendations, the report serves as a guide for policymakers, healthcare leaders and pharmacy stakeholders seeking to strengthen vaccination services through integrated, sustainable models.

An executive summary is available here and an accompanying infographic summarising key global trends and outcomes.